Cold Spring Harbor Asia Conference on Differentiation Therapy and Advances in Cancer
Conference Details
Location: Suzhou, China
Dates: October 20-24, 2012
Website: http://www.csh-asia.org/differ12.html
Organizers
Saijuan Chen, Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China
Zhu Chen, Ministry of Health P.R. China / Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China
Samuel Waxman, The Mount Sinai Medical Center, USA
Conference Overview
This Cold Spring Harbor conference, merged with the biennial International Conference on Differentiation Therapy (ICDI), is recognized as one of the highest-level international scientific meetings in the field of cancer research. The conference focuses on differentiation therapy, which has shown a targeted, cancer-selective therapeutic effect, transforming acute promyelocytic leukemia from a highly fatal disease to a curable one. The conference aims to reflect the most updated advancements in differentiation cancer therapies.
Major Topics
Epigenetics and Epigenomics
Mechanism and impact on cancer therapy
Genetics and Genomics of Cancer
Cancer stem cells and novel targets
Animal models and novel targets
Targeted Therapies: Present and Future
Differentiation Therapy of APL and Beyond
Keynote Speakers
Stephen Baylin, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, USA
Zhu Chen, Ministry of Health P.R. China / Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China
Carlo Croce, Ohio State University, USA
Samuel Waxman, The Mount Sinai Medical Center, USA
Invited Speakers
Saijuan Chen, Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China
John Crispino, Northwestern University, USA
Riccardo Dalla-Favera, Columbia University, USA
Hugues de Thé, Université Paris 7/CNRS, France
Tariq Enver, UCL Cancer Institute, UK
Lorraine Gudas, Weill Cornell Medical College, USA
Zeguang Han, Shanghai Jiaotong University, China
Gunther Hartmann, Universitätsklinikum Bonn, Germany
Scott Hiebert, Vanderbilt University, USA
Shai Izraeli, Sheba Medical Center, Israel
Phillip Koeffler, National University of Singapore, Singapore
Xin Lu, Ludwig Institute For Cancer Research Ltd, UK
Ari Melnick, Weill Cornell Medical College, USA
Tomoki Naoe, Nagoya University Graduate School of Medicine, Japan
Benjamin Neel, Ontario Cancer Institute/MaRs Centre, Canada
Ryuzo Ohno, Aichi Cancer Center Hospital, Japan
Michael Rosenfeld, HHMI/University of California, San Diego, USA
Yongfeng Shang, Tianjin Medical University, China
Yang Shi, Harvard Medical School, USA
Martin Tallman, Memorial Sloan-Kettering Cancer Center, USA
Daniel Tenen, Cancer Science Institute of Singapore, NUS, Singapore
Jun Wang, BIG-Shenzhen, China
Yue Xiong, University of North Carolina at Chapel Hill, USA
Arthur Zelent, Institute of Cancer Research, UK
Yixin Zeng, Peking Union Medical College, China
Qimin Zhan, Peking Union Medical College, China
Contact Information
Cold Spring Harbor Asia
No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China
Tel: +86-512-62729029
Fax: +86-512-62729028
Email: mikeji@cshl.edu
Website: www.csh-asia.org
苏州市 | 独墅湖会议酒店
2012.10.2010.24
分享到